Wilma Townsend DPT Team Leader November 20 2014 Objectives 1 increase the fields knowledge of medication units and their usefulness and barriers to implementation 2 demonstrate how medication units increase treatment capacity and access to care ID: 702854
Download Presentation The PPT/PDF document "Introduction to Providing Medication Ass..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1Slide2
Introduction to Providing Medication Assisted Treatment through Medication Units
Wilma Townsend
DPT, Team Leader
November 20, 2014Slide3
Objectives
(
1) increase the field’s knowledge of medication units and their usefulness and barriers to implementation;
(
2) demonstrate how medication units increase treatment capacity and access to care,
(
3) provide guidance on current demographic settings where medication units currently exist and thrive and
(
4) discuss the cost benefits of Implementing medication units to expand access to care. Slide4
What you will hear today
The rules and regulations from SAMHSA and DEA
The experience and role of the State in the development of medication units
The experiences, successes and barriers in starting a medication units from the program’s perspectives
The cost benefits of a medication unit Slide5
What is stated in the Code of Federal Regulations (1 of 2)
Medication Units are facilities established as part of, but geographically separate from, an opioid treatment program from which licensed private practitioners or community pharmacists dispense or administer an opioid agonist treatment medication or collect samples for drug testing or analysis.
CFR 42, part 8, 8.2, 8.12Slide6
What is stated in the Code of Federal Regulations (2 of 2)
Certified OTPs may establish medication units that are authorized to dispense opioid agonist treatment medications for observed ingestion.
Before establishing a medication unit, a certified OTP must notify SAMHSA by submitting form SMA-162
The OTP must also comply with the provisions of 21 CFR part 1300
Medication units shall comply with all pertinent state laws and regulations
CFR 42, part 8, Subpart B, 8.11 (i)Slide7
Survey Findings
34 States and Puerto Rico responded
2 States (KY, MA) and Puerto Rico have Medication Units
KY 4 units, PR 2 units, MA unspecified
5 States (ME, MN, OR, WA, WI) indicated that Medicaid reimburse for client travel to access an OTP
Over 60% of States reported that some clients travel over 76 miles
8 states reported policies or issues that would prevent development of MU
20 States reported that they would like to have more information and technical assistance on MU
Compiled by NASADAD Slide8
Cost
Some States have Medicaid reimburse for transportation for
transporting patients to
OTPs
This have
been raised as a factor in some state Medicaid
plans
States may want to evaluate the cost of Medicaid reimbursement of transporting patients vs. the cost of establishing medication unitSlide9
Introduction of Presenters
DEA – Mr. James Arnold, Chief Policy Unit
Kentucky’s State Opioid Treatment Authority – Mr. Mark Fisher
Pinnacle Treatment
Centers’ medication unit – Ms. Holly BroceSlide10
Instructions
Presentation
Questions at the end of each presentation
In the chat session you can type in your questions
If we do not get to your questions we will have the presenters to answer them in writing after the presentation and we will put them on the DPT website with the slides of this webinarSlide11
Evaluation
Please complete the evaluation at the end of the webinar
Let us know if there are other topics you would like for us to present in the future.